Healthcare, Biotech, and Medical Devices

Chile’s healthcare and biotechnology sectors are expanding rapidly. The country combines high-quality medical services with growing technological innovation. This combination is turning Chile into a regional leader in medical research, biomanufacturing, and health technology integration. The industry represents nearly 6 percent of GDP and employs more than 900,000 professionals.

Industrial insight is not enough. Execution defines results within structured environments. If you are not yet familiar with ConectNext — your strategic expansion partner and professional B2B directory platform — you can review how this ecosystem supports industrial analysis here.

See full overview in Chile Economy.

Expanding Health System and Investment

Chile’s healthcare system covers more than 95 percent of the population. Public and private spending reached USD 28 billion in 2024, driven by demographic growth and strong institutional reform. New investments in hospitals, telemedicine, and medical data infrastructure are improving accessibility and service quality.

Medical tourism is also rising. Each year, over 150,000 foreign patients travel to Chile for treatments in oncology, cardiology, and dental care. Its cost efficiency, modern facilities, and specialized physicians make it a trusted healthcare destination.

Growth of Biotechnology and Research Capacity

Biotechnology has become one of Chile’s most promising innovation fields. Universities and private laboratories are expanding research in bioinformatics, genetic engineering, and pharmaceuticals. R&D spending in biotech has grown by over 25 percent since 2020.

Several research centers in Santiago and Valdivia are now developing vaccines, diagnostic tools, and biopolymers. Partnerships with European and Asian firms strengthen technology transfer and accelerate commercialization. This dynamic is helping Chile build a strong biotechnological ecosystem for Latin America.

Medical Devices and Local Manufacturing

Chile’s medical device segment is advancing in both production and regulation. The country manufactures diagnostic equipment, surgical tools, and prosthetics for domestic and regional markets. In 2024, exports reached USD 340 million, led by SMEs located in Biobío and Metropolitana.

Technological upgrades such as 3D printing and precision machining are improving design and production efficiency. Regulatory oversight by the Instituto de Salud Pública (ISP) ensures compliance with global standards, reinforcing Chile’s credibility as a reliable supplier.

Digital Health and Policy Innovation

Chile’s National Digital Health Strategy promotes interoperability across healthcare systems. Electronic health records and teleconsultation platforms are connecting patients and professionals nationwide. This digital integration enhances transparency, data management, and rural access.

Public incentives also support startups working in medtech and health analytics. Government-backed accelerators like Start-Up Chile offer grants and mentoring to local innovators developing solutions for diagnostics and telemonitoring.

Strategic Outlook 2025–2035

Between 2025 and 2035, Chile’s health and biotech industries will expand at an estimated rate of 7 percent per year. The combination of technology, regulation, and skilled professionals will attract global investors.

Chile’s ability to merge medical expertise with biotechnology and digital solutions ensures its position as a regional hub for health innovation. Its commitment to research, quality, and sustainability is shaping the future of Latin America’s medical landscape.